Skip to content
Home/Companies/Pharma/Ascend Gene & Cell Therapies
Ascend Gene & Cell Therapies

Ascend Gene & Cell Therapies

Pharma·France·Active
Entry
–
Hold
–
Status
Active

Who owns Ascend Gene & Cell Therapies?

Ascend Gene & Cell Therapies is a French Pharma company, currently owned by Cathay Capital.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Cathay Capital
Investor
Cathay Capital
Cathay Health · 2021 · Growth

Key facts

HQFrance
SectorPharma
Websitewww.ascend-adv.com

More from Cathay Health

Other portfolio companies in the same fund.

Ganymed Robotics
Ganymed Robotics
Active
MedTechFrance· 2022
Moon Surgical
Moon Surgical
Active
MedTechFrance· 2022
Initiate Studios
Initiate Studios
Active
HealthcareUS· 2021
Kojin Therapeutics
Exited 2025
BiotechUS· 2021
Tissium
Active
MedTechFrance· 2021

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns Ascend Gene & Cell Therapies?

Ascend Gene & Cell Therapies is currently owned by Cathay Capital, through Cathay Health.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue